Unilever-McCormick Deal Concerns Ease Ahead of Unilever Earnings
MKC is trading near its 52-week low of $44.82 (12% above the low).
Summary
Investor anxiety around the $15.7B Unilever Foods merger with McCormick is fading, with Barclays noting the planned London secondary listing is winning over skeptical Unilever shareholders. The deal is part of Unilever's pivot to beauty and personal care, and its standalone portfolio could deliver 5.9% growth, justifying a higher multiple. Unilever reports Q2 results Tuesday, with underlying sales growth expected at 4.3% and turnover of €12.9B. This follows McCormick's own strong Q2 and the $2B term loan secured in May to fund the deal. The merger remains on track, and the improving sentiment removes a key overhang for McCormick shares.
At the time of this announcement, MKC was trading at $50.05 on NYSE in the Trade & Services sector, with a market capitalization of approximately $13.4B. The 52-week trading range was $44.82 to $73.84. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.